TCR2 Therapeutics Inc logo

TCRR - TCR2 Therapeutics Inc News Story

$16.92 0.1  0.4%

Last Trade - 07/08/20

Sector
Healthcare
Size
Mid Cap
Market Cap £415.8m
Enterprise Value £319.2m
Revenue £n/a
Position in Universe 2900th / 6395

BRIEF-Tcr² Therapeutics Reports Q1 2020 Financial Results

Thu 14th May, 2020 11:51am
May 14 (Reuters) - TCR2 Therapeutics Inc  TCRR.O :
    * TCR² THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * QTRLY LOSS PER SHARE $0.65
    * ENDED Q1 OF 2020 WITH $140.7 MILLION IN CASH, CASH
EQUIVALENTS,
AND INVESTMENTS
    * PROJECTS NET CASH USE OF $60-70 MILLION FOR 2020
    * UPDATING OUR TC-210 GUIDANCE TO EXPECT AN INTERIM UPDATE
FROM
PHASE 1 PORTION IN MID-2020
    * Q1 EARNINGS PER SHARE VIEW $-0.61 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9wdHdy 
Further company coverage:  TCRR.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.